PhaseⅠ/Ⅱ Study of URLC10-177 and TTK-567 Peptide Vaccine Combined With CpG7909 in Patients With Esophageal Cancer

NCT00669292 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

BIOLOGICAL: URLC10-177, TTK-567, CpG-7909

Sponsor

Wakayama Medical University

Collaborators

[object Object]